| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |